Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2018

View Archived Issues

Adipose-derived regenerative cell therapy safe in patients with erectile dysfunction

Polymorphisms in miRNA-146a and IRAK1 are associated with susceptibility to SLE and MS

Harbour BioMed licenses ex-China rights to Kelun-Biotech's A-167

Common pathway may underlie schizophrenia and PD

Getting at stored mRNAs part of fragile X problem

HDAC inhibitors optimized for CNS drug-like properties and hematological safety

Phase Ib data guide Novan's development of SB-414 for atopic dermatitis

New oral selective apelin agonist AM-2995 developed for heart disease treatment

Chugai's describes candidate for the treatment of hyperphosphatemia EOS-798

Novo Nordisk reports topline PIONEER 5 results for oral semaglutide

Phase III study of MC2-01 cream in psoriasis vulgaris meets primary and secondary endpoints

Biogen identifies new NRF2 activators

Adare Pharmaceuticals describes cysteamine prodrugs

Antiangiogenic compounds synthesized at Celgene

Vectura completes pediatric studies with VR-647 for asthma

Hanmi Science patents oncolytic compounds

New Rho kinase inhibitors described by Chiesi Farmaceutici

Japanese approval for Tagrisso as first-line treatment of EGFR-mutated NSCLC

Phase II trial of TLC-599 for osteoarthritis pain meets primary and key secondary endpoints

FDA approves expanded label for Keytruda for first-line treatment of metastatic non-squamous NSCLC

Ascentage Pharma opens phase I trial of APG-2575 in hematologic malignancies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...